Health utility of patients with advanced gastrointestinal stromal tumors (GIST) after failure of imatinib and sunitinib: findings from GRID, a randomized, double-blind, placebo-controlled phase III study of regorafenib versus placebo
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1436-3305
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Health utility of patients with advanced gastrointestinal stromal tumors (GIST) after failure of imatinib and sunitinib: findings from GRID, a randomized, double-blind, placebo-controlled phase III study of regorafenib versus placebo ; volume:18 ; number:3 ; day:24 ; month:6 ; year:2014 ; pages:627-634 ; date:7.2015
Gastric cancer ; 18, Heft 3 (24.6.2014), 627-634, 7.2015
- Creator
-
Poole, Chris D.
- Contributor
-
Connolly, Mark P.
Chang, Jane
Currie, Craig J.
SpringerLink (Online service)
- DOI
-
10.1007/s10120-014-0391-x
- URN
-
urn:nbn:de:1111-201609109457
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:46 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Poole, Chris D.
- Connolly, Mark P.
- Chang, Jane
- Currie, Craig J.
- SpringerLink (Online service)
Other Objects (12)
Regorafenib bei GIST : neuer Therapie-Standard bei Progress nach Imatinib und Sunitinib
Effect of gastrointestinal resection on sunitinib exposure in patients with GIST
Placebo
Neural Mechanisms of Placebo Anxiolysis
Toxicity management of regorafenib in patients with gastro-intestinal stromal tumour (GIST) in a tertiary cancer centre
An enactive account of placebo effects
Study protocol of REGOSARC trial: activity and safety of regorafenib in advanced soft tissue sarcoma: a multinational, randomized, placebo-controlled, phase II trial
Placebo-controlled clinical trials: how trial documents justify the use of randomisation and placebo
Neural circuit basis of placebo pain relief
Role of placebo samples in observational studies
Imaginary pills and open-label placebos can reduce test anxiety by means of placebo mechanisms
76. Placebo domino
Regorafenib bei GIST : neuer Therapie-Standard bei Progress nach Imatinib und Sunitinib
Effect of gastrointestinal resection on sunitinib exposure in patients with GIST
Placebo
Neural Mechanisms of Placebo Anxiolysis
Toxicity management of regorafenib in patients with gastro-intestinal stromal tumour (GIST) in a tertiary cancer centre
An enactive account of placebo effects
Study protocol of REGOSARC trial: activity and safety of regorafenib in advanced soft tissue sarcoma: a multinational, randomized, placebo-controlled, phase II trial
Placebo-controlled clinical trials: how trial documents justify the use of randomisation and placebo
Neural circuit basis of placebo pain relief
Role of placebo samples in observational studies
Imaginary pills and open-label placebos can reduce test anxiety by means of placebo mechanisms
76. Placebo domino
Regorafenib bei GIST : neuer Therapie-Standard bei Progress nach Imatinib und Sunitinib
Effect of gastrointestinal resection on sunitinib exposure in patients with GIST
Placebo
Neural Mechanisms of Placebo Anxiolysis
Toxicity management of regorafenib in patients with gastro-intestinal stromal tumour (GIST) in a tertiary cancer centre
An enactive account of placebo effects
Study protocol of REGOSARC trial: activity and safety of regorafenib in advanced soft tissue sarcoma: a multinational, randomized, placebo-controlled, phase II trial
Placebo-controlled clinical trials: how trial documents justify the use of randomisation and placebo
Neural circuit basis of placebo pain relief
Role of placebo samples in observational studies
Imaginary pills and open-label placebos can reduce test anxiety by means of placebo mechanisms